
Meet Natalie Stanback: Breakthrough T1D 2023 Children’s Congress Chair
She knows T1D; she knows Advocacy—and she knows how to get things done on Capitol Hill! Meet the Breakthrough T1D 2023 Children's Congress Natalie Stanback.

National Clinical Care Commission Final Report Published
The National Clinical Care Commission issued its report to Congress, which included a recommendation for a five-year renewal of the Special Diabetes Program.

Special Diabetes Program (SDP) Renewed for Three Years!
One of Breakthrough T1D’s top legislative priorities has been achieved with the enactment of a three-year renewal of the Special Diabetes Program (SDP). The program, now funded until September 30, 2023 at $150 million per year, will enable researchers to build upon the momentum in type 1 diabetes (T1D) to date and explore new opportunities […]

Cass Freeland Builds Relationships with Political Power Players
NDAM Profile: Breakthrough T1D advocate Cass Freeland’s expertise in connecting with policy makers demonstrates The Power of Us.

FDA Approves an Artificial Pancreas System for Children Aged 2-6 Years
The Food and Drug Administration (FDA) approved the Medtronic MiniMed 770G artificial pancreas system for use by children aged 2 to 6 with type 1 diabetes (T1D). It is the first marketed device that can automatically adjust insulin delivery based on continuous glucose monitoring (CGM) values for children aged 2-6 years.

Tandem Control-IQ—Now Authorized For Children
Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology in children ages six and older.

Enhanced Charitable Giving Incentives Explained: What it Means for Donors in 2020
What the federal economic relief package, also known as the CARES Act (Coronavirus Aid, Relief, and Economic Security) means for donors to Breakthrough T1D.

Special Diabetes Program Funding Extended Allowing Critical Type 1 Diabetes Research to Continue
The Federal Government has continued its commitment to support diabetes research by providing more than $75 million into the Special Diabetes Program (SDP), which drives forward critical research aimed at curing type 1 diabetes (T1D) and improving the lives of those living with the disease today. The funding, approved by both the House and Senate and signed by the […]

FDA Welcomes Teen Perspective During Children’s Congress
What would intimidate even the most seasoned speakers had little impact on the three teens who met with the Food and Drug Administration (FDA) on behalf of Breakthrough T1D and the type one diabetes (T1D) community. The teens have already been through so much. Sharing their stories of living with T1D, they said, is easy […]

Breakthrough T1D Youth Delegates Urge Senators to Continue Support of Type One Diabetes Research
In a packed U.S. Senate hearing room, Breakthrough T1D Children’s Congress Delegates, medical leaders, and celebrities today shared the personal, critical need for ongoing federal funding of research for type 1 diabetes (T1D). The two senators leading the hearing responded with promises to fight on behalf of everyone in the hearing, and the entire T1D […]